News – Page 129 – Endpoints News

Lilly bests Novo Nordisk in observational study of GLP-1 drugs

10 months ago

When can pharma companies correct online misinformation? FDA explains

10 months ago

Digital health deals rallied in the first half of 2024, though funding still trails last year

10 months ago

Infections are major cause of non-relapse deaths after CAR-T cell therapy, study shows

10 months ago

HilleVax's stock tumbles after Phase 2b norovirus vaccine fails in infants

10 months ago

Exclusive: Gene insertion startup launches with new integrase technology from University of Hawaii

10 months ago

Vanqua raises $45M; Aerovate to look for strategic alternatives

10 months ago

Ideaya showcases proof-of-concept data in a boost to synthetic lethality play

10 months ago

Lilly discloses its first biotech acquisition of the year, buying Morphic for $3.2B

10 months ago

With cash expected to run dry, Inventiva ramps up search for funding

10 months ago

VC firm emerges to boost Austrian biotech scene that’s ‘ready to break out’

10 months ago

In pivot to buzzy ADCs, London biotech Myricx raises $114M with Lilly's support

10 months ago

Eli Lilly’s Alzheimer’s OK; GSK picks its mRNA bets; Megaround tally; Biosecure's shadow; and more

10 months ago

Circle Pharma raises $54M as part of Series D while macrocycles heat up

10 months ago

Innovent reworks deal with IASO; Granza raises $7M

10 months ago

UK trade group slams Novo, Novartis, Pfizer and Otsuka for code breaches

10 months ago

Avid Bio’s 2024 revenue drops; Lotte Bio breaks ground on new $3.3B site

10 months ago

Roche’s TIGIT drug tiragolumab flunks another Phase 3 lung cancer test

10 months ago

Federal judge tosses Boehringer Ingelheim's IRA lawsuit, deciding Medicare negotiations are voluntary

10 months ago

Experts want to make it easier to get RSV vaccines. Did they make it harder instead?

10 months ago

Mississippi judge rejects efforts by Novartis, PhRMA to block 340B state law

10 months ago

In biotech's uneven recovery, 50 startups raised megarounds in first half of 2024

10 months ago

Apollomics plans to lay off staff, narrow focus for lung cancer trial

10 months ago

Pfizer adds ex-State Street CEO to the board; Two Merus execs head for the exit

10 months ago

First page Previous page 126 127 128129130 131 132 Next page Last page